A future early phase clinical trials centre has received funding via the State government’s Future Health Research and Innovation (FHRI) Fund.
$2.25 million has been allocated towards not-for-profit Linear Clinical Research’s new centre in Joondalup.
Early phase trials represent the first step in testing new medicines developed in the laboratory.
The funding will go towards the renovating and fitting out of the existing 930 square metre building, located on the corner of Lakeside Drive and Boas Avenue.
“The Future Health Research and Innovation Fund is a key initiative of the McGowan Government in driving Western Australia’s world-class medical research industry,” said Medical Research Minister Stephen Dawson.
“Providing critical resources to establish a state-of-the-art research facility will not only help health and medical research to flourish, it will benefit all Western Australians.
The project will also create jobs and help to diversify WA’s economy and advance WA’s standing as a leader in health and medical research.
Stephen Dawson, Medical Research Minister
Centre to drive medical innovation
With over 1,200 trial participants expected to take part in trials at the centre annually, the facility will be working closely with the Joondalup Health Campus.
The building will feature 4 beds and three separate zones that support infection control and provision of multiple trial designs.
First-in-human, drug-to-drug interaction and vaccine and biosimilar trials will be among thos taking palce at the centre.
Additionally, it will house specimen collection facilities, pre-processing laboratory, clinical trial pharmacy facilities, information and communication technologies, and volunteer recreation facilities.
Jayden Rogers, Linear Clinical Research CEO, said he was thrilled with the funding.
“The COVID-19 pandemic has shown the world just how important clinical trials are, not only in fighting disease, but also in driving medical innovation and economic growth,” he said.
“This is evident in Linear’s contribution to the COVID-19 fight and investment in expanding facilities.
“The FHRI Fund support will help us deliver one of the most advanced clinical trial centres in the entire Asia-Pacific region, which will help position WA as a leading destination for biopharmaceutical companies and support Linear’s mission to ‘Nurture Breakthroughs’.”
